We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Inflamyloid: What Is It and Why Is It Important in Alzheimer's Disease?

Article   Oct 25, 2018 | by Ruairi J Mackenzie, Science Writer for Technology Networks

 
 Inflamyloid: What Is It and Why Is It Important in Alzheimer's Disease?

AstraZeneca's Damian Crowther gave a webinar on the imflamyloid October 24 on Technology Networks.

 
 
 

RELATED ARTICLES

Making Neuroscience More Credible at BNA 2019

Article

At the British Neuroscience Association's Festival of Neuroscience 2019, we pulled aside one of the BNA's credibility board, Dr Verena Heise to ask her about credibility in neuroscience, how she became involved in promoting it, and how other players in research can help advance the credibility cause.

READ MORE

Whole-Exome Sequencing at the Dawn of Personalized Medicine

Article

Deciphering the first complete sequence of the human genome in 2003 required a combined effort of scientists from 20 institutions and $3 billion of funding. Over the last decade, whole-exome sequencing (WES) established itself as a method that successfully balances cost and the output of useful data for diagnostic or research applications. Here, we look at how WES is used in both the laboratory and the clinic, and why it is a preferred method of choice in such areas.

READ MORE

Antibodies in Research: The Good, the Bad, and the Validation Epidemic

Article

The specificity of antibody binding is incredibly important for many research disciplines, yet sourcing the best antibody for your research can be a challenge. This is partly because not all suppliers validate their antibodies sufficiently. How much of a problem is this?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE